Effects of Treatment on Exercise Tolerance, Cardiac Function, and Mortality in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis

Study Questions:

Do pharmacologic therapies in heart failure with preserved ejection fraction (HFPEF) impact exercise capacity, diastolic function, or mortality?